Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$84.98 - $122.67 $11,217 - $16,192
-132 Reduced 4.93%
2,546 $0
Q3 2022

Oct 17, 2022

SELL
$76.35 - $94.18 $122,007 - $150,499
-1,598 Reduced 37.37%
2,678 $216,000
Q2 2022

Jul 28, 2022

BUY
$67.99 - $132.89 $210,633 - $411,693
3,098 Added 262.99%
4,276 $318,000
Q1 2022

Apr 27, 2022

SELL
$94.08 - $130.2 $1,411 - $1,952
-15 Reduced 1.26%
1,178 $603,000
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $11,298 - $14,165
-87 Reduced 6.8%
1,193 $641,000
Q3 2021

Oct 13, 2021

SELL
$106.71 - $143.18 $1,387 - $1,861
-13 Reduced 1.01%
1,280 $700,000
Q2 2021

Aug 02, 2021

BUY
$80.99 - $107.93 $1,214 - $1,618
15 Added 1.17%
1,293 $552,000
Q1 2021

Apr 20, 2021

SELL
$84.79 - $104.74 $5,002 - $6,179
-59 Reduced 4.41%
1,278 $459,000
Q4 2020

Feb 08, 2021

BUY
$78.0 - $104.5 $104,286 - $139,716
1,337 New
1,337 $494,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Alta Wealth Advisors LLC Portfolio

Follow Alta Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Wealth Advisors LLC with notifications on news.